European Nanomedicine Characterization Laboratory

Información del proyecto

EUNCL

Identificador del acuerdo de subvención: 654190

DOI

10.3030/654190

Proyecto cerrado

Fecha de la firma de la CE 26 Junio 2015

Fecha de inicio 1 Mayo 2015

Fecha de finalización 31 Diciembre 2019

Financiado con arreglo a

• EXCELLENT SCIENCE - Research Infrastructures

Coste total

€ 5 627 303,50

Aportación de la UE

€ 4 995 181,00

Coordinado por

COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
France

CORDIS proporciona enlaces a los documentos públicos y las publicaciones de los proyectos de los programas marco HORIZONTE.

Los enlaces a los documentos y las publicaciones de los proyectos del Séptimo Programa Marco, así como los enlaces a algunos tipos de resultados específicos, como conjuntos de datos y «software», se obtienen dinámicamente de OpenAIRE .

Resultado final

Documents, reports (27)

Liaison activities with external stakeholders –final report

A final report on the Liaison activities with external stakeholders will be prepared.

1st scientific report on Structure Activity Relationship studies
2nd report on reviews of QMS of EU-NCL
2nd scientific report on mode of action studies
Liaison activities with external stakeholders – 1st report
2nd Prioritized list of candidate technologies
3rd report on reviews of QMS of EU-NCL
1st completed survey with regulatory bodies
Activities to promote innovation through partnership with industry– 3rd report
2nd Completed survey with regulatory bodies
1st report on reviews of QMS of EU-NCL
CMS implemented
1st Data management plan
1st List of candidate technologies
2nd Data management plan
2nd report on the testing and optimization of novel technologies
1st report on modeling of analytical decision process
3rd Completed survey with regulatory bodies
3rd Data Management Plan

3rd Sample Management Report

1st report on the testing and optimization of novel technologies
Activities to promote innovation through partnership with industry – 2nd report

Activities to promote innovation through partnership with industry– 2nd report

Activities to promote innovation through partnership with industry– 1st report
2nd List of candidate technologies
2nd scientific report on Structure Activity Relationship studies
1st Prioritized list of candidate technologies
1st scientific report on mode of action studies
2nd report on modeling of analytical decision process

Websites, patent fillings, videos etc. (9)

Publication of 2nd TNA open call
EU-NCL annual workshop –year 3
Publication of 1st TNA open call
Publication of “State-of-the-art” manuscript – version 1
EU-NCL annual workshop –year 2
Publication of “State-of-the-art” manuscript – version 2
EU-NCL annual workshop – year 4
EU-NCL website
Publication of 3rd TNA open call

Demonstrators, pilots, prototypes (5)

3rd Collection of approved measurement SOPs
2nd Collection of approved measurement SOPs
1st Collection of approved measurement SOPs
Sample receiving laboratory installed
4th Collection of approved measurement SOPs

Other (3)

TNA “guide for applicant” & evaluation form
CMS developed
Appointment of the peer review evaluation board

Publicaciones

Peer reviewed articles (6)

Analytical ultracentrifugation for analysis of doxorubicin loaded liposomes

Autores: Dora Mehn, Patrizia Iavicoli, Noelia Cabaleiro, Sven Even Borgos, Fanny Caputo, Otmar Geiss, Luigi Calzolai, François Rossi, Douglas Gilliland
Publicado en: International Journal of Pharmaceutics, Edición 523/1, 2017, Página(s) 320-326, ISSN 0378-5173
Editor: Elsevier BV
DOI: 10.1016/j.ijpharm.2017.03.046

Measuring Particle Size Distribution by Asymmetric Flow Field Flow Fractionation: A Powerful Method for the Preclinical Characterization of Lipid-Based Nanoparticles

Autores: Fanny Caputo, Amandine Arnould, Maria Bacia, Wai Li Ling, Emilie Rustique, Isabelle Texier, Adriele Prina Mello, Anne-Claude Couffin
Publicado en: Molecular Pharmaceutics, Edición 16/2, 2018, Página(s) 756-767, ISSN 1543-8384
Editor: American Chemical Society
DOI: 10.1021/acs.molpharmaceut.8b01033

Are existing standard methods suitable for the evaluation of nanomedicines: some case studies

Autores: Sabrina Gioria, Fanny Caputo, Patricia Urbán, Ciarán Manus Maguire, Susanne Bremer-Hoffmann, Adriele Prina-Mello, Luigi Calzolai, Dora Mehn
Publicado en: Nanomedicine, Edición 13/5, 2018, Página(s) 539-554, ISSN 1743-5889
Editor: Future Medicine Ltd.
DOI: 10.2217/nnm-2017-0338

Larger or more? Nanoparticle characterisation methods for recognition of dimers

Autores: D. Mehn, F. Caputo, M. Rösslein, L. Calzolai, F. Saint-Antonin, T. Courant, P. Wick, D. Gilliland
Publicado en: RSC Advances, Edición 7/44, 2017, Página(s) 27747-27754, ISSN 2046-2069
Editor: Royal Society of Chemistry
DOI: 10.1039/c7ra02432k

Measuring particle size distribution of nanoparticle enabled medicinal products, the joint view of EUNCL and NCI-NCL. A step by step approach combining orthogonal measurements with increasing complexity

Autores: F. Caputo, J. Clogston, L. Calzolai, M. Rösslein, A. Prina-Mello
Publicado en: Journal of Controlled Release, Edición 299, 2019, Página(s) 31-43, ISSN 0168-3659
Editor: Elsevier BV
DOI: 10.1016/j.jconrel.2019.02.030

Sound understanding of environmental, health and safety, clinical, and market aspects is imperative to clinical translation of nanomedicines

Autores: Matthias Rösslein, Neill J. Liptrott, Andrew Owen, Patrick Boisseau, Peter Wick, Inge K. Herrmann
Publicado en: Nanotoxicology, Edición 11/2, 2017, Página(s) 147-149, ISSN 1743-5390
Editor: Informa Healthcare
DOI: 10.1080/17435390.2017.1279361

Book chapters (1)

Multiparametric Preclinical Assessment of Theranostics Materials

Autores: Adriele Prina-Mello
Publicado en: Handbook of Nanomaterials for Cancer Theranostics, 2018, Página(s) 517-535, ISBN 9780-128133392
Editor: Elsevier
DOI: 10.1016/b978-0-12-813339-2.00017-7